Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

NCT07418138 · clinicaltrials.gov ↗

COMPLETED

Status

484

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation
Hepatocellular Carcinoma (HCC)
Tyrosine Kinase Inhibitor
Survival Rate

Interventions

OTHER: Medication history
OTHER: Medication history

Sponsor

Hu Liangshuo